Enovix Corporation (NASDAQ:ENVX) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Enovix Corporation (NASDAQ:ENVX) have received a consensus rating of “Moderate Buy” from the ten analysts that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $15.65.

ENVX has been the subject of a number of analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Enovix in a research report on Monday, December 29th. JPMorgan Chase & Co. cut their price target on Enovix from $12.00 to $10.00 and set a “neutral” rating for the company in a report on Wednesday, November 12th. Craig Hallum reduced their price target on Enovix from $16.00 to $10.00 and set a “buy” rating on the stock in a research note on Thursday. Northland Securities set a $16.00 price objective on Enovix in a research report on Monday, November 17th. Finally, Cantor Fitzgerald dropped their target price on Enovix from $30.00 to $25.00 and set an “overweight” rating for the company in a research note on Thursday, November 6th.

Key Stories Impacting Enovix

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: Q4 results beat expectations: revenue of ~$11.3M (+~16% YoY) topped estimates and EPS/loss was slightly better than forecast; gross profit and operating-loss improvement were highlighted on the call — a fundamental bright spot supporting longer‑term growth potential. SA Q4 Presentation
• Positive Sentiment: Multiple outlets noted the revenue and EPS beats and operational improvement (higher gross profit, narrower operating loss), which help the growth narrative even as profitability remains distant. Yahoo Finance: Q4 Report
• Neutral Sentiment: Unusual options activity: a large block of call buying (≈31,896 calls) indicates speculative/leveraged interest that may amplify intraday moves but doesn’t change fundamentals. AAII Options Note
• Neutral Sentiment: Some analysts lowered price targets but kept constructive ratings (e.g., Canaccord trimmed its PT but remains “Buy”), which mutes upside while signaling continued long‑term conviction from parts of the sell‑side. Benzinga: Canaccord Note
• Negative Sentiment: Near‑term guidance disappointed: Q1 FY2026 revenue guidance ($6.5M–$7.5M) came in well below consensus (~$8.8M), a key proximate reason for selling pressure as it implies slower near‑term growth. Company Press Release / Deck
• Negative Sentiment: Analyst downgrades/target cuts: TD Cowen cut its target sharply and moved to “Hold,” and other firms trimmed targets — increasing near‑term downside risk as sell‑side expectations are reset. Benzinga: TD Cowen Note
• Negative Sentiment: New risk disclosure highlights rising geopolitical/trade exposure (U.S.–China tensions) that could pressure supply chains and margins — a fresh governance/operational risk investors must price in. TipRanks: Risk Disclosure
• Negative Sentiment: Balance‑sheet and liquidity signals are concerning to some investors: cash fell year‑over‑year and total liabilities rose materially; coupled with insider sales called out in reporting, that has likely amplified selling. Quiver Quant: Financials

Enovix Trading Down 11.4%

Enovix stock opened at $5.27 on Monday. The stock has a 50-day moving average price of $7.10 and a 200 day moving average price of $8.87. Enovix has a 52 week low of $5.24 and a 52 week high of $16.49. The stock has a market cap of $1.14 billion, a PE ratio of -6.84 and a beta of 2.15. The company has a current ratio of 8.34, a quick ratio of 8.13 and a debt-to-equity ratio of 1.90.

Institutional Investors Weigh In On Enovix

A number of institutional investors have recently bought and sold shares of ENVX. Jupiter Asset Management Ltd. acquired a new position in Enovix in the third quarter worth about $2,465,000. Perennial Investment Advisors LLC raised its stake in Enovix by 50.2% during the second quarter. Perennial Investment Advisors LLC now owns 366,100 shares of the company’s stock valued at $3,785,000 after buying an additional 122,278 shares in the last quarter. XTX Topco Ltd acquired a new stake in Enovix during the second quarter valued at approximately $1,107,000. Baird Financial Group Inc. lifted its holdings in Enovix by 24.0% during the 2nd quarter. Baird Financial Group Inc. now owns 721,930 shares of the company’s stock worth $7,465,000 after buying an additional 139,617 shares during the last quarter. Finally, Electron Capital Partners LLC grew its position in shares of Enovix by 5.3% in the 2nd quarter. Electron Capital Partners LLC now owns 7,066,293 shares of the company’s stock worth $73,065,000 after acquiring an additional 353,530 shares in the last quarter. 50.92% of the stock is currently owned by hedge funds and other institutional investors.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.